(Q34460383)

2 August 2017

1 reference

title

Cold-attenuated live influenza vaccines, a risk-benefit assessment (English)

1 reference

2 August 2017

1 reference

Pfleiderer M

1

1 reference

2 August 2017

Löwer J

series ordinal

2

1 reference

2 August 2017

Kurth R

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

5-6

1 reference

2 August 2017

page(s)

886-894

1 reference

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Safe administration of influenza vaccine to patients with egg allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Safe administration of the measles vaccine to children allergic to eggs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

The replication of type A influenza viruses in the infant rat: a marker for virus attenuation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Patterns of Shedding of Myxoviruses and Paramyxoviruses in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Comparison of infection rats and severity of illness for influenza A subtypes H1N1 and H3N2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of Schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900386-3

7 January 2021

10.1016/S0264-410X(01)00386-3

Identifiers

DOI

1 reference

2 August 2017

1 reference